These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19645635)

  • 21. Targeting inflammation in the treatment of type 2 diabetes.
    Donath MY
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():193-6. PubMed ID: 24003937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach.
    Fernández-Veledo S; Nieto-Vazquez I; Vila-Bedmar R; Garcia-Guerra L; Alonso-Chamorro M; Lorenzo M
    Arch Physiol Biochem; 2009 Oct; 115(4):227-39. PubMed ID: 19673658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do local immune-neuroendocrine disturbances initiate diabetes?
    Murzenok P; Goranov V
    Can J Physiol Pharmacol; 1999 Mar; 77(3):147-55. PubMed ID: 10535687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Growth and regeneration potential abnormalities of pancreatic beta-cells in GK rats, NIDDM mellitus model].
    Portha B; Movassat J; Plachot C; Saulnier C
    Journ Annu Diabetol Hotel Dieu; 1999; ():25-38. PubMed ID: 10732402
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune regulation of islet homeostasis and adaptation.
    Guo J; Fu W
    J Mol Cell Biol; 2020 Oct; 12(10):764-774. PubMed ID: 32236479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell therapy for type 2 diabetes: is it desirable and can we get it?
    Halban PA
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():205-11. PubMed ID: 18834449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.
    Donath MY; Størling J; Maedler K; Mandrup-Poulsen T
    J Mol Med (Berl); 2003 Aug; 81(8):455-70. PubMed ID: 12879149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Type 2 diabetes mellitus as a subclinical inflammation].
    Skrha J
    Cas Lek Cesk; 2010; 149(6):277-81. PubMed ID: 20662474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammatory reactions in patients suffering from coronary artery disease with concomitant obesity and type 2 diabetes mellitus].
    Chukaeva II; Orlova NV; Aleshkin VA; Pukhal'skiĭ AL; Alekseeva EG; Gorina ON; Shmarina GV; Zakharova OV
    Klin Med (Mosk); 2008; 86(1):27-30. PubMed ID: 18326279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid oligomers in diabetic and nondiabetic human pancreas.
    Zhao HL; Sui Y; Guan J; He L; Gu XM; Wong HK; Baum L; Lai FM; Tong PC; Chan JC
    Transl Res; 2009 Jan; 153(1):24-32. PubMed ID: 19100955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
    J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research.
    Grossi SG
    Ann Periodontol; 2001 Dec; 6(1):138-45. PubMed ID: 11887456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Of mighty mice and diabetic men: animal models of islet dysfunction.
    Efendic S; Boitard C; Ferrannini E; Henquin JC; Steiner DF; Cerasi E
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():1-4. PubMed ID: 17919172
    [No Abstract]   [Full Text] [Related]  

  • 35. The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes.
    Hogan MF; Hull RL
    Diabetologia; 2017 Jun; 60(6):952-959. PubMed ID: 28396983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of oxidative stress in the pathogenesis of diabetes.
    Kaneto H; Katakami N; Kawamori D; Miyatsuka T; Sakamoto K; Matsuoka TA; Matsuhisa M; Yamasaki Y
    Antioxid Redox Signal; 2007 Mar; 9(3):355-66. PubMed ID: 17184181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic stellate cells in the islets as a novel target to preserve the pancreatic β-cell mass and function.
    Yang Y; Kim JW; Park HS; Lee EY; Yoon KH
    J Diabetes Investig; 2020 Mar; 11(2):268-280. PubMed ID: 31872946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.
    Morris DL
    Mol Endocrinol; 2015 Jul; 29(7):946-62. PubMed ID: 26001058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus and apoptosis: inflammatory cells.
    Ryan A; Murphy M; Godson C; Hickey FB
    Apoptosis; 2009 Dec; 14(12):1435-50. PubMed ID: 19360474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of high pancreatic islet and white adipose tissue blood flow in type 2 diabetic GK rats by administration of the beta3-adrenoceptor inhibitor SR-59230A.
    Pettersson US; Henriksnäs J; Jansson L
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E490-4. PubMed ID: 19491297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.